HHS Launches SURPASS and New Efforts to Accelerate Faster, Smarter Clinical Trials
ARPA-H says the program will combine adaptive trial design, computational models and real-time analysis; STAT reports that funding details were not included in the initial announcement.
TL;DR
- HHS launched SURPASS, an ARPA-H program intended to use computational models, shared trial infrastructure and real-time analysis in clinical-trial design.
- STAT reports that the initiative will accept proposals later this fall and that the initial announcement did not specify funding or participant resources.
- The program sits alongside separate projects on clinical-site activation, data infrastructure and patient navigation.
HHS said SURPASS will develop adaptive platform trials using predictive models, shared infrastructure and real-time analysis. The agency also announced three related projects focused on increasing clinical-site capacity, linking trial data and helping patients navigate research opportunities. [1]
STAT independently reported that SURPASS is a five-year program expected to begin accepting proposals later this fall. It noted that the initial announcement did not specify funding for the initiatives or what resources participants would receive. [2]
Why it matters
HHS is treating trial design, data access and operating capacity as connected parts of U.S. biotechnology competitiveness. The release sets out program goals, while key implementation details remain open.
Editor's note
HHS is the primary source; STAT independently confirms the program and identifies funding and participant support as unresolved details.